Study on gastric empty disorder after the gastric ulcer healing and therapeutic effect of cisapride

Zou Kaifang , Liu Shi , Liu Jinsong , Liu Yongge , Hou Xiaohua , Yi Cuiqiong

Current Medical Science ›› 2000, Vol. 20 ›› Issue (1) : 57 -58.

PDF
Current Medical Science ›› 2000, Vol. 20 ›› Issue (1) : 57 -58. DOI: 10.1007/BF02887678
Article

Study on gastric empty disorder after the gastric ulcer healing and therapeutic effect of cisapride

Author information +
History +
PDF

Abstract

Gastric emptying time of liquid meal was detected by using ultrasonography in 28 gastric ulcer patients with continual or recurrent dyspepsia symptoms after the ulcer healing. Sixteen out of 28 patients (57.1 %) with a delay of gastric emptying time (T1/2) were randomly divided into two groups: 8 cases were treated with cisapride 5 mg three times a day and 8 cases with cisapride 10 mg three times a day respectively. The results showed that cisapride could relieve the symptoms with the effective rate being 68.8 % in the two groups. T1/2 in the patients after treatment with cisapride was significantly shorter than before treatment (P < 0.001). It was concluded that there is a delay of T1/2 in some patients with gastric ulcer healing. Cisapride could promote gastric empty of liquid meal and relieve the symptoms efficiently. The effect of lower dose of cisapride is similar to that of higher dose.

Keywords

gastric ulcer / gastric emptying / cisapride

Cite this article

Download citation ▾
Zou Kaifang, Liu Shi, Liu Jinsong, Liu Yongge, Hou Xiaohua, Yi Cuiqiong. Study on gastric empty disorder after the gastric ulcer healing and therapeutic effect of cisapride. Current Medical Science, 2000, 20(1): 57-58 DOI:10.1007/BF02887678

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

1995, 34(3):18

[2]

1992,31 (10): 623

[3]

PerriF, GhoosY F, MaesB D, et al.. Gastric emptying and Helicobacter pylori infection in duodenal ulcer disease. Dig Dis Sci, 1996, 41: 462-462

[4]

1998. 252

[5]

FarragiaG, CamillerM, WhiteheadW E. Therapeutic strategies for motility disorders. Gastroenterol Clin North Am, 1996, 25: 225-225

[6]

1996, 16(4):187

[7]

ElsseleR, BrunnerG, SimonB, et al.. Gastric mucosa during treatment with lansoprazole: Helicobacter pylorisa risk factor argyrophil cell hyperplasia. Gastroenterology, 1997, 112: 7.7-7.7

AI Summary AI Mindmap
PDF

97

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/